Filing Details

Accession Number:
0001209191-16-116763
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-02 16:50:15
Reporting Period:
2016-05-02
Filing Date:
2016-05-02
Accepted Time:
2016-05-02 16:50:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365369 F John Sheridan C/O Tandem Diabetes Care, Inc.,
11045 Roselle Street
San Diego CA 92121
Evp, Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-02 2,000 $1.11 7,295 No 4 M Direct
Common Stock Disposition 2016-05-02 2,000 $10.61 5,295 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2016-05-02 2,000 $0.00 2,000 $1.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
102,040 2014-02-25 2023-04-23 No 4 M Direct
Footnotes
  1. The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2015, in multiple transactions at prices ranging from $10.55 to $11.00. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  2. The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.